MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CVAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CureVac (CVAC) Ownership - Who owns CureVac?

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.05B
P/E Ratio
6.98
Total Cash
419.21M
Projected Growth
N/A
Total Debt
35.07M
Revenue
70.74M
Risk (Beta)
2.42
Dividend Yield
N/A
Total Cash/Share
1.86
Total Debt/Equity
N/A
Revenue/Share
0.37 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)
Annualized Return+19%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CVAC
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company developing tumour immunotherapy

Industry Biotechnology

Profile
Details
Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com